The p53-PUMA axis suppresses iPSC generation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23873265.
- Also identified by DOI 10.1038/ncomms3174 and PMC identifier 4394110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mechanisms underlying the reprogramming process of induced pluripotent stem cells remain poorly defined. Like tumorigenesis, generation of induced pluripotent stem cells was shown to be suppressed by the Trp53 (p53) pathway, at least in part via p21Cdkn1a (p21)-mediated cell cycle arrest. Here we examine the role of PUMA, a pro-apoptotic mediator of p53, during somatic reprogramming in comparison to p21 in the p53 pathway. Using mouse strains deficient in these molecules, we demonstrate that PUMA is an independent mediator of the negative effect of p53 on induced pluripotent stem cell induction. PUMA deficiency leads to a better survival rate associated with reduced DNA damage and fewer chromosomal aberrations in induced pluripotent stem cells, whereas loss of p21 or p53 results in an opposite outcome. Given these new findings, PUMA may serve as a distinct and more desirable target in the p53 pathway for induced pluripotent stem cell generation, thereby having important implications for potential therapeutic applications of induced pluripotent stem cells.
Medical subject headings
- Apoptosis Regulatory Proteins
- Cyclin-Dependent Kinase Inhibitor p21
- Fibroblasts
- Gene Expression Regulation, Developmental
- Induced Pluripotent Stem Cells
- Tumor Suppressor Protein p53
- Tumor Suppressor Proteins